Acknowledgement
We would like to thank Leena Lim and Editage (www.editage.co.kr) for English language editing.
References
- Diana M, Liu YY, Pop R, Kong SH, Legner A, Beaujeux R, et al. Superselective intra-arterial hepatic injection of indocyanine green (ICG) for fluorescence image-guided segmental positive staining: experimental proof of the concept. Surg Endosc 2017;31:1451-1460. https://doi.org/10.1007/s00464-016-5136-y
- Huh YJ, Lee HJ, Kim TH, Choi YS, Park JH, Son YG, et al. Efficacy of assessing intraoperative bowel perfusion with near-infrared camera in laparoscopic gastric cancer surgery. J Laparoendosc Adv Surg Tech A 2019;29:476-483. https://doi.org/10.1089/lap.2018.0263
- Park SH, Berlth F, Choi JH, Park JH, Suh YS, Kong SH, et al. Near-infrared fluorescence-guided surgery using indocyanine green facilitates secure infrapyloric lymph node dissection during laparoscopic distal gastrectomy. Surg Today 2020;50:1187-1196. https://doi.org/10.1007/s00595-020-01993-w
- Connell CM, Doherty GJ. Activating HER2 mutations as emerging targets in multiple solid cancers. ESMO Open 2017;2:e000279. https://doi.org/10.1136/esmoopen-2017-000279
- Tajima JY, Futamura M, Gaowa S, Mori R, Tanahashi T, Tanaka Y, et al. Clinical significance of glycoprotein non-metastatic B and its association with EGFR/HER2 in gastrointestinal cancer. J Cancer 2018;9:358-366. https://doi.org/10.7150/jca.20266
- Scholl S, Beuzeboc P, Pouillart P. Targeting HER2 in other tumor types. Ann Oncol 2001;12 Suppl 1:S81-S87. https://doi.org/10.1093/annonc/12.suppl_1.S81
- Gravalos C, Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 2008;19:1523-1529. https://doi.org/10.1093/annonc/mdn169
- Plum PS, Gebauer F, Kramer M, Alakus H, Berlth F, Chon SH, et al. HER2/neu (ERBB2) expression and gene amplification correlates with better survival in esophageal adenocarcinoma. BMC Cancer 2019;19:38. https://doi.org/10.1186/s12885-018-5242-4
- Kanayama K, Imai H, Usugi E, Shiraishi T, Hirokawa YS, Watanabe M. Association of HER2 gene amplification and tumor progression in early gastric cancer. Virchows Arch 2018;473:559-565. https://doi.org/10.1007/s00428-018-2433-y
- Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010;376:687-697. https://doi.org/10.1016/S0140-6736(10)61121-X
- Kolb HC, Finn MG, Sharpless KB. Click chemistry: diverse chemical function from a few good reactions. Angew Chem Int Ed Engl 2001;40:2004-2021. https://doi.org/10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5
- Kong SH, Noh YW, Suh YS, Park HS, Lee HJ, Kang KW, et al. Evaluation of the novel near-infrared fluorescence tracers pullulan polymer nanogel and indocyanine green/γ-glutamic acid complex for sentinel lymph node navigation surgery in large animal models. Gastric Cancer 2015;18:55-64. https://doi.org/10.1007/s10120-014-0345-3
- Noh YW, Kong SH, Choi DY, Park HS, Yang HK, Lee HJ, et al. Near-infrared emitting polymer nanogels for efficient sentinel lymph node mapping. ACS Nano 2012;6:7820-7831. https://doi.org/10.1021/nn301949y
- Kim TH, Kong SH, Park JH, Son YG, Huh YJ, Suh YS, et al. Assessment of the completeness of lymph node dissection using near-infrared imaging with indocyanine green in laparoscopic gastrectomy for gastric cancer. J Gastric Cancer 2018;18:161-171. https://doi.org/10.5230/jgc.2018.18.e19
- van Keulen S, van den Berg NS, Nishio N, Birkeland A, Zhou Q, Lu G, et al. Rapid, non-invasive fluorescence margin assessment: Optical specimen mapping in oral squamous cell carcinoma. Oral Oncol 2019;88:58-65. https://doi.org/10.1016/j.oraloncology.2018.11.012
- Tewari M, Kumar A, Mishra RR, Kumar M, Shukla HS. HER2 expression in gastric and gastroesophageal cancer: report from a tertiary care hospital in North India. Indian J Surg 2015;77:447-451. https://doi.org/10.1007/s12262-013-0871-y
- Guideline Committee of the Korean Gastric Cancer Association (KGCA), Development Working Group & Review Panel. Korean practice guideline for gastric cancer 2018: an evidence-based, multi-disciplinary approach. J Gastric Cancer 2019;19:1-48. https://doi.org/10.5230/jgc.2019.19.e8
- Kong SH, Bae SW, Suh YS, Lee HJ, Yang HK. Near-infrared fluorescence lymph node navigation using indocyanine green for gastric cancer surgery. J Minim Invasive Surg 2018;21:95-105. https://doi.org/10.7602/jmis.2018.21.3.95
- Bernhard W, Barreto K, El-Sayed A, Gonzalez C, Viswas RS, Toledo D, et al. Pre-clinical study of IRDye800CW-nimotuzumab formulation, stability, pharmacokinetics, and safety. BMC Cancer 2021;21:270. https://doi.org/10.1186/s12885-021-08003-3
- de Valk KS, Deken MM, Schaap DP, Meijer RP, Boogerd LS, Hoogstins CE, et al. Dose-finding study of a CEA-targeting agent, SGM-101, for intraoperative fluorescence imaging of colorectal cancer. Ann Surg Oncol 2021;28:1832-1844. https://doi.org/10.1245/s10434-020-09069-2
- Cao Q, Liu S, Niu G, Chen K, Yan Y, Liu Z, et al. Phage display peptide probes for imaging early response to bevacizumab treatment. Amino Acids 2011;41:1103-1112. https://doi.org/10.1007/s00726-010-0548-9
- Kim JW, Kim HP, Im SA, Kang S, Hur HS, Yoon YK, et al. The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines. Cancer Lett 2008;272:296-306. https://doi.org/10.1016/j.canlet.2008.07.018
- Tran T, Engfeldt T, Orlova A, Sandstrom M, Feldwisch J, Abrahmsen L, et al. (99m)Tc-maEEEZ(HER2:342), an affibody molecule-based tracer for the detection of HER2 expression in malignant tumors. Bioconjug Chem 2007;18:1956-1964. https://doi.org/10.1021/bc7002617
- Leung K. IRDye 800-albumin-binding domain-fused-ZHER2:342 affibody. In: Molecular Imaging and Contrast Agent Database (MICAD). Bethesda: National Center for Biotechnology Information; 2004.
- Matsui Y, Inomata M, Tojigamori M, Sonoda K, Shiraishi N, Kitano S. Suppression of tumor growth in human gastric cancer with HER2 overexpression by an anti-HER2 antibody in a murine model. Int J Oncol 2005;27:681-685.
- Lee SB, Hassan M, Fisher R, Chertov O, Chernomordik V, Kramer-Marek G, et al. Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res 2008;14:3840-3849. https://doi.org/10.1158/1078-0432.CCR-07-4076
- Moshakis V, McIlhinney RA, Raghavan D, Neville AM. Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies. Br J Cancer 1981;44:91-99. https://doi.org/10.1038/bjc.1981.153